Page last updated: 2024-09-04

docetaxel anhydrous and casopitant

docetaxel anhydrous has been researched along with casopitant in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (casopitant)	Trials (casopitant)	Recent Studies (post-2010) (casopitant)
12,110	3,216	6,920	43	17	21

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, LM; Bauman, J; Dandamudi, UB; Gartner, E; Hohl, R; Johnson, B; Lewis, LD; Morris, S; Murray, S; Webb, RT	1

Trials

1 trial(s) available for docetaxel anhydrous and casopitant

Article	Year
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:4 Topics: Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Docetaxel; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Least-Squares Analysis; Leukocyte Count; Male; Middle Aged; Neoplasms; Neurokinin-1 Receptor Antagonists; Neutrophils; Ondansetron; Piperazines; Piperidines; Taxoids	2011

Article

Year

Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.

Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:4

Topics: Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Docetaxel; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Least-Squares Analysis; Leukocyte Count; Male; Middle Aged; Neoplasms; Neurokinin-1 Receptor Antagonists; Neutrophils; Ondansetron; Piperazines; Piperidines; Taxoids

2011